Evidence map›Paper›PMID 40926161›Full record

ArticleJournal of nephrology2025

Prevalence and characteristics of treatments for sleep disordered breathing in people receiving dialysis: a scoping review.

Daniel S March, Lizelle Bernhardt, Kelly Barber, Ffion Curtis, Patrick J Mowles, Nina Morris, Ellesha A Smith, Sonny Vargeson, James O Burton

Abstract readScoping Review
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Daniel S March *Department of Cardiovascular Sciences, University of Leicester, John Walls' Renal Unit, University Hospitals of Leicester NHS Trust, Leicester, UK. dsm12@leicester.ac.uk.ORCID http://orcid.org/0000-0002-1468-6918
Lizelle Bernhardt *Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
Kelly BarberLeicestershire Partnership NHS Trust, Leicester, UK.
Ffion CurtisLiverpool Reviews and Implementation Group, Institute of Population Health, University of Liverpool, Liverpool, UK.
Patrick J MowlesLeicester Medical School, University of Leicester, Leicester, UK.
Nina MorrisLeicestershire Partnership NHS Trust, Leicester, UK.
Ellesha A SmithDepartment of Population Health Sciences, University of Leicester, Leicester, UK.
Sonny VargesonLeicester Medical School, University of Leicester, Leicester, UK.
James O BurtonDepartment of Cardiovascular Sciences, University of Leicester, John Walls' Renal Unit, University Hospitals of Leicester NHS Trust, Leicester, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIndividuals with kidney failure experience elevated cardiovascular risk, potentially worsened by the presence of sleep disordered breathing. Despite this association, prevalence of sleep apnoea, and evidence for effective treatments are poorly understood in people with kidney failure. This review examines sleep apnoea prevalence, types of sleep apnoea, and treatment interventions in people with kidney failure receiving dialysis.

methodsGuidelines for scoping reviews were followed and the following databases were searched for both peer reviewed and grey literature: MEDLINE, EMBASE, CINAHL, Cochrane Central Register of Controlled Trials (CENTRAL), ClinicalTrials.gov, the Web of Sciences Core Collection, OpenGrey, ETHos and ProQuest. All databases were searched from inception to 18th October, 2024. Random-effects proportional meta-analysis was used to estimate prevalence. A narrative synthesis of the interventions from the included studies for sleep apnoea was reported.

resultsThere were 36 included studies. Pooled data from 19 studies indicated that sleep apnoea prevalence was 59% (95% CI 47%, 70%). Pooled data estimated mild apnoea prevalence at 21% (95% CI 16%, 26%) (11 included studies), with moderate and severe prevalence being 44% (95% CI 30%, 60%) (14 included studies). The majority of sleep apnoea was obstructive (75% (95% CI 53%, 89%)) with the remaining being central (15% (95% CI 8%, 28%)) and mixed (15% (95% CI 3%, 49%)) in nature.

conclusionThe prevalence of sleep apnoea is high in people receiving dialysis. Currently there is insufficient evidence for the effective treatment of sleep apnoea in this population.

Indexed as

Kidney Failure, ChronicRenal DialysisSleep Apnea SyndromesHumansPrevalenceContinuous positive airway pressureDialysisMeta-analysisScoping reviewSleep apnoea

Identifiers

PMID40926161
PMCPMC12630318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.